Towards optimal design of anti-malarial pharmacokinetic studies

Towards optimal design of anti-malarial pharmacokinetic studies

Bibliographic Details
Main Authors:	Simpson, Julie A, Jamsen, Kris M, Price, Ric N, White, Nicholas J, Lindegardh, Niklas, Tarning, Joel, Duffull, Stephen B
Format:	Online
Language:	English
Published:	BioMed Central 2009
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2732628/

Similar Items

Optimal designs for population pharmacokinetic studies of oral artesunate in patients with uncomplicated falciparum malaria
by: Jamsen, Kris M, et al.
Published: (2011)

Optimal designs for population pharmacokinetic studies of the partner drugs co-administered with artemisinin derivatives in patients with uncomplicated falciparum malaria
by: Jamsen, Kris M, et al.
Published: (2012)

A robust design for identification of the Parasite Clearance Estimator
by: Jamsen, Kris M, et al.
Published: (2013)

Assessing the utility of an anti-malarial pharmacokinetic-pharmacodynamic model for aiding drug clinical development
by: Zaloumis, Sophie, et al.
Published: (2012)

Pharmacokinetics of Piperaquine in Pregnant Women in Sudan with Uncomplicated Plasmodium falciparum Malaria
by: Adam, Ishag, et al.
Published: (2012)

Statistical Power Calculations for Mixed Pharmacokinetic Study Designs Using a Population Approach
by: Kloprogge, Frank, et al.
Published: (2014)

Population Pharmacokinetic Assessment of the Effect of Food on Piperaquine Bioavailability in Patients with Uncomplicated Malaria
by: Tarning, Joel, et al.
Published: (2014)

Pharmacokinetics of Orally Administered Oseltamivir in Healthy Obese and Nonobese Thai Subjects
by: Jittamala, Podjanee, et al.
Published: (2014)

Population pharmacokinetics of Artemether and dihydroartemisinin in pregnant women with uncomplicated Plasmodium falciparum malaria in Uganda
by: Tarning, Joel, et al.
Published: (2012)

A population pharmacokinetic model of piperaquine in pregnant and non-pregnant women with uncomplicated Plasmodium falciparum malaria in Sudan
by: Hoglund, Richard M, et al.
Published: (2012)

Liquid chromatographic–mass spectrometric method for simultaneous determination of small organic acids potentially contributing to acidosis in severe malaria☆
by: Sriboonvorakul, Natthida, et al.
Published: (2013)

The Future of Anti-Malarial Research
by: Senior-White, Ronald, et al.
Published: (1927)

Benefits of a Pharmacology Antimalarial Reference Standard and Proficiency Testing Program Provided by the Worldwide Antimalarial Resistance Network (WWARN)
by: Lourens, Chris, et al.
Published: (2014)

Nonlinear Mixed-Effects Modelling of In Vitro Drug Susceptibility and Molecular Correlates of Multidrug Resistant Plasmodium falciparum
by: Simpson, Julie A., et al.
Published: (2013)

OptiMal-PK: an internet-based, user-friendly interface for the mathematical-based design of optimized anti-malarial treatment regimens
by: Aljayyoussi, Ghaith, et al.
Published: (2016)

Pharmacokinetic and Pharmacodynamic Considerations in Antimalarial Dose Optimization
by: White, Nicholas J.
Published: (2013)

A Randomized Pilot Study of L-Arginine Infusion in Severe Falciparum Malaria: Preliminary Safety, Efficacy and Pharmacokinetics
by: Yeo, Tsin W., et al.
Published: (2013)

Artesunate/dihydroartemisinin pharmacokinetics in acute falciparum malaria in pregnancy: absorption, bioavailability, disposition and disease effects
by: McGready, Rose, et al.
Published: (2012)

Orally Formulated Artemisinin in Healthy Fasting Vietnamese Male Subjects: A Randomized, Four-Sequence, Open-Label, Pharmacokinetic Crossover Study
by: Hien, Tran Tinh, et al.
Published: (2011)

Immunity as a predictor of anti-malarial treatment failure: a systematic review
by: Katherine O’Flaherty, et al.
Published: (2017-04-01)

Population pharmacokinetics of oseltamivir and oseltamivir carboxylate in obese and non‐obese volunteers
by: Chairat, Kalayanee, et al.
Published: (2016)

Pharmacokinetic Interactions between Primaquine and Chloroquine
by: Pukrittayakamee, Sasithon, et al.
Published: (2014)

Punjab Anti-Malarial Campaign
Published: (1911)

Anti-Malarial Operations in India
by: Bose, P. N.
Published: (1941)

Anti-Malarial Sanitation in India
Published: (1904)

Anti-Malarial Sanitation in India
by: Goodbody, C. M.
Published: (1904)

The Synthetic Anti-Malarial Compounds
Published: (1933)

Severe Malarial Thrombocytopenia: A Risk Factor for Mortality in Papua, Indonesia
by: Lampah, Daniel A., et al.
Published: (2015)

Pharmacokinetics and pharmacodynamics of intravenous artesunate during severe malaria treatment in Ugandan adults
by: Byakika-Kibwika, Pauline, et al.
Published: (2012)

Repositioning: the fast track to new anti-malarial medicines?
by: Lotharius, Julie, et al.
Published: (2014)

An Approach for Identifiability of Population Pharmacokinetic–Pharmacodynamic Models
by: Shivva, V, et al.
Published: (2013)

Anti-malarial effect of gum arabic
by: Ballal, Adil, et al.
Published: (2011)

Biological evaluation of hydroxynaphthoquinones as anti-malarials
by: Schuck, Desiree C, et al.
Published: (2013)

Anti-Malarial Measures, Ancient and Modern
by: Hamilton, H.
Published: (1905)

Fake anti-malarials: start with the facts
by: Kaur, Harparkash, et al.
Published: (2016)

Artemisinin anti-malarial drugs in China
by: Guo, Zongru
Published: (2016)

Lumefantrine and Desbutyl-Lumefantrine Population Pharmacokinetic-Pharmacodynamic Relationships in Pregnant Women with Uncomplicated Plasmodium falciparum Malaria on the Thailand-Myanmar Border
by: Kloprogge, Frank, et al.
Published: (2015)

Intravenous pharmacokinetics, oral bioavailability, dose proportionality and in situ permeability of anti-malarial lumefantrine in rats
by: Wahajuddin, et al.
Published: (2011)

Potent in vivo anti-malarial activity and representative snapshot pharmacokinetic evaluation of artemisinin-quinoline hybrids
by: Lombard, Marli C, et al.
Published: (2013)

Antiplasmodial activity, in vivo pharmacokinetics and anti-malarial efficacy evaluation of hydroxypyridinone hybrids in a mouse model
by: Dambuza, Ntokozo S., et al.
Published: (2015)